DIHEXA Peptide

VANDL peptides are manufactured and lyophilized entirely within the United States. The domestic production pipeline ensures full chain-of-custody visibility, from raw API sourcing through final lyophilization and vial closure. Every step of the process occurs under rigorous quality control protocols in certified U.S. facilities. Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. This product is intended exclusively for in vitro research and laboratory use by qualified professionals. It is not approved for human or veterinary use, consumption, or therapeutic application. This product has not been evaluated by the FDA or any equivalent regulatory authority.

Peptide

DIHEXA

Strength

5 mg

Package

3 mL vial

Purity

≥98% (HPLC)

Form

vial